Matthew Taylor

Assistant Professor

  • 2467 Citations
  • 10 h-Index
20102018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Thyroid Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Safety Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Local Neoplasm Recurrences Medicine & Life Sciences
Placebos Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

  • 2467 Citations
  • 10 h-Index
  • 18 Article
  • 1 Comment/debate
32 Citations

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

Patel, M. R., Ellerton, J., Infante, J. R., Agrawal, M., Gordon, M., Aljumaily, R., Britten, C. D., Dirix, L., Lee, K. W., Taylor, M., Schöffski, P., Wang, D., Ravaud, A., Gelb, A. B., Xiong, J., Rosen, G., Gulley, J. L. & Apolo, A. B., Jan 1 2018, In : The Lancet Oncology. 19, 1, p. 51-64 14 p.

Research output: Contribution to journalArticle

Platinum
Carcinoma
Neoplasms
Safety
avelumab
74 Citations

Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children

Drilon, A., Laetsch, T. W., Kummar, S., Dubois, S. G., Lassen, U. N., Demetri, G. D., Nathenson, M., Doebele, R. C., Farago, A. F., Pappo, A. S., Turpin, B., Dowlati, A., Brose, M. S., Mascarenhas, L., Federman, N., Berlin, J., El-Deiry, W. S., Baik, C., Deeken, J., Boni, V. & 18 othersNagasubramanian, R., Taylor, M., Rudzinski, E. R., Meric-Bernstam, F., Sohal, D. P. S., Ma, P. C., Raez, L. E., Hechtman, J. F., Benayed, R., Ladanyi, M., Tuch, B. B., Ebata, K., Cruickshank, S., Ku, N. C., Cox, M. C., Hawkins, D. S., Hong, D. S. & Hyman, D. M., Feb 22 2018, In : New England Journal of Medicine. 378, 8, p. 731-739 9 p.

Research output: Contribution to journalArticle

Neoplasms
Research Personnel
tropomyosin kinase
Confidence Intervals
Safety
5 Citations

Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study

Gambacorti-Passerini, C., Orlov, S., Zhang, L., Braiteh, F., Huang, H., Esaki, T., Horibe, K., Ahn, J. S., Beck, J. T., Edenfield, W. J., Shi, Y., Taylor, M., Tamura, K., Van Tine, B. A., Wu, S. J., Paolini, J., Selaru, P. & Kim, T. M., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasms
Lymphoma
Confidence Intervals
Safety
7 Citations

Precision targeted therapy with BLU-667 for RET-driven cancers

Subbiah, V., Gainor, J. F., Rahal, R., Brubaker, J. D., Kim, J. L., Maynard, M., Hu, W., Cao, Q., Sheets, M. P., Wilson, D., Wilson, K. J., Dipietro, L., Fleming, P., Palmer, M., Hu, M. I., Wirth, L., Brose, M. S., Ou, S. H. I., Taylor, M., Garralda, E. & 5 othersMiller, S., Wolf, B., Lengauer, C., Guzi, T. & Evans, E. K., Jul 1 2018, In : Cancer Discovery. 8, 7, p. 836-849 14 p.

Research output: Contribution to journalArticle

Transfection
Neoplasms
Thyroid Neoplasms
Therapeutics
Non-Small Cell Lung Carcinoma
4 Citations

Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials

Kelly, K., Infante, J. R., Taylor, M. H., Patel, M. R., Wong, D. J., Iannotti, N., Mehnert, J. M., Loos, A. H., Koch, H., Speit, I. & Gulley, J. L., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Clinical Trials
Safety
Neoplasms
avelumab
CD274 Antigen